• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tardive dyskinesia in northern Israel: preliminary study.

作者信息

Schwartz M, Silver H, Tal I, Sharf B

机构信息

Department of Neurology, Faculty of Medicine, Bnai Zion Medical Center, Acre, Israel.

出版信息

Eur Neurol. 1993;33(3):264-6. doi: 10.1159/000116951.

DOI:10.1159/000116951
PMID:8096816
Abstract

Tardive dyskinesia (TD) is an iatrogenic syndrome caused by long-term treatment with neuroleptics and is characterized by abnormal involuntary movements in the orofacial region, lingual dyskinesia and in some cases dyskinesia also in the extremities, head and trunk. In the present study we found 20% TD in chronic-neuroleptic-treated patients with a significantly greater prevalence in females (27% of the total population), and a higher frequency in older patients. In males, patients who received electroconvulsive therapy had a significantly lower prevalence of TD. 23 patients had seizures; 7 of these suffered from TD, all of them female.

摘要

相似文献

1
Tardive dyskinesia in northern Israel: preliminary study.
Eur Neurol. 1993;33(3):264-6. doi: 10.1159/000116951.
2
Abnormal involuntary movements in patients on long-acting neuroleptics.
Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):719-23. doi: 10.1016/0278-5846(83)90052-0.
3
Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.印度精神分裂症患者迟发性运动障碍的患病率及相关风险因素。
Asian J Psychiatr. 2014 Jun;9:31-5. doi: 10.1016/j.ajp.2013.12.010. Epub 2014 Jan 4.
4
Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.难治性精神分裂症患者停用抗精神病药物:迟发性运动障碍与超敏性精神病无关。
Schizophr Res. 2003 Sep 1;63(1-2):151-60. doi: 10.1016/s0920-9964(02)00338-9.
5
Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa.
Schizophr Res. 2005 Jul 1;76(1):89-97. doi: 10.1016/j.schres.2004.10.009. Epub 2004 Dec 1.
6
Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.间歇性抗精神病药物治疗与迟发性运动障碍风险:库拉索锥体外系综合征研究III
Am J Psychiatry. 1998 Apr;155(4):565-7. doi: 10.1176/ajp.155.4.565.
7
Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
Schizophr Res. 2006 Jan 31;81(2-3):139-43. doi: 10.1016/j.schres.2005.07.032. Epub 2005 Oct 25.
8
Tardive dyskinesia in elderly psychiatric patients in Singapore.新加坡老年精神病患者的迟发性运动障碍
Aust N Z J Psychiatry. 1991 Mar;25(1):119-22. doi: 10.3109/00048679109077725.
9
The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.菲律宾精神分裂症患者迟发性运动障碍的现患率及相关因素。
Parkinsonism Relat Disord. 2009 Nov;15(9):655-9. doi: 10.1016/j.parkreldis.2009.02.015. Epub 2009 Apr 5.
10
A prospective study of tardive dyskinesia in Japan.日本迟发性运动障碍的前瞻性研究。
Eur Arch Psychiatry Clin Neurosci. 1991;240(4-5):250-4. doi: 10.1007/BF02189535.

引用本文的文献

1
Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three cases.氟伏沙明治疗精神分裂症患者迟发性运动障碍和迟发性静坐不能的有益作用:三例报告。
Psychiatry Investig. 2013 Dec;10(4):417-20. doi: 10.4306/pi.2013.10.4.417. Epub 2013 Oct 24.
2
Beneficial effects of the sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with postpsychotic depressive disorder of schizophrenia: report of 5 cases.西格玛-1受体激动剂氟伏沙明对精神分裂症后抑郁障碍患者迟发性运动障碍的有益作用:5例报告
Prim Care Companion CNS Disord. 2012;14(6). doi: 10.4088/PCC.12br01401. Epub 2012 Nov 8.
3
Tardive dyskinesia in non-western countries: a review.
非西方国家的迟发性运动障碍:综述
Eur Arch Psychiatry Clin Neurosci. 1995;246(1):47-52. doi: 10.1007/BF02191814.